World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application
Jennifer McDonell(Multiple Sclerosis Society of Canada), Peer Baneke(Multiple Sclerosis International Federation), Gavin Giovannoni(Queen Mary University of London), Kathleen Costello(National Multiple Sclerosis Society), Brenda Banwell(Johns Hopkins University), Joanna Laurson-Doube(Multiple Sclerosis International Federation), Nick Rijke(Multiple Sclerosis International Federation)
Cited by 5
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863